Extrapelvic endometriosis involving pudendal and sciatic nerve may be a cause of lower limb pain.
View Article and Find Full Text PDFAm J Obstet Gynecol
August 2024
Background: Traditionally, curettage has been the most widely performed surgical intervention for removing retained products of conception. However, hysteroscopic removal is increasingly performed as an alternative because of the potentially lower risk of intrauterine adhesions and higher rates of complete removal. Until recently, studies comparing curettage with hysteroscopic removal regarding reproductive and obstetrical outcomes were limited, and data conflicting.
View Article and Find Full Text PDFObjective: The aim of this follow-up study is to compare a manually driven hysteroscopic tissue removal system (Resectr 9 Fr) with a motor driven system (Truclear) in terms of long-term clinical outcomes such as abnormal uterine bleeding and polyp recurrence.
Study Design: This is a follow-up of a multicenter randomized controlled trial comparing a manually and motor driven hysteroscopic tissue removal system for polypectomy. This prospective cohort study was performed at Ghent University Hospital (Ghent, Belgium) and Catharina Hospital Eindhoven (Eindhoven, the Netherlands).
Eur J Obstet Gynecol Reprod Biol X
December 2023
Objectives: To compare intrauterine adhesion (IUA) formation after hysteroscopic removal (HR) of retained products of conception (RPOC) with IUA formation after ultrasound-guided electric vacuum aspiration (EVA) and externally validate the outcomes of an RCT.
Study Design: This prospective cohort study was conducted from April 2015 until June 2022 in 2 Dutch teaching hospitals and one Belgian university hospital. Women opting for EVA underwent the procedure as soon as possible.
Objective: To study the comparison between hysteroscopic morcellation (HM) of retained products of conception (RPOC) with ultrasound (US)-guided electric vacuum aspiration in terms of intrauterine adhesion (IUA) formation, efficacy, and complications.
Design: A randomized controlled, nonblinded trial.
Setting: Three teaching hospitals and one university hospital from April 2015 to June 2022.